Rabbit IgG Purification Media / Human IgG Purification Media / IgG Subclass Purification Media: The Complete Guide to Choosing

In experiments like preparing polyclonal antibodies, developing human monoclonal drugs, and analyzing autoimmune disease subtypes, rabbit IgG purification media, human IgG purification media, and IgG subtype purification media are three core types of affinity chromatography consumables. The binding abilities of Protein A and Protein G ligands vary greatly across different species and IgG subtypes. Choosing the wrong one can directly lead to low antibody yields, high contamination proteins, and poor experimental reproducibility. 

Quick selection tip in one sentence: use Protein A for rabbit IgG, Protein A for human IgG1/2/4, Protein G for human IgG3/total IgG, and identify special subtypes before choosing the media.

1. Why does the IgG subtype determine purification efficiency?

  Comparison of the Binding Properties of Protein A, Protein G and IgG Subtypes

IgG makes up more than 70% of the total serum immunoglobulins, but it’s not just a single molecule — based on structural differences in the constant region of the heavy chain, IgG can be further divided into multiple subtypes.

Humans have four IgG subtypes: IgG1, IgG2, IgG3, and IgG4. In serum, IgG1 accounts for about 60%–65%, IgG2 about 20%–25%, IgG3 around 5%–10%, and IgG4 roughly 3%–6%. The four subtypes share over 90% sequence homology, but they vary significantly in hinge length, the number of disulfide bonds, and Fc receptor binding capacity.

Rabbit IgG is a completely different story — unlike humans and mice, domestic rabbits only express a single IgG subclass (with a single functional IGHG gene), so there’s no subtype division like IgG1/IgG2. Individual variation is mostly seen in allotypes of the heavy chain and κ light chain (like a1/a2/a3, b4/b5/b6/b9, d11/d12, e14/e15).

Why care about subtypes? Because binding strength to affinity resins is subtype-specific. Take Protein A as an example: it binds strongly to human IgG1, IgG2, and IgG4, but very weakly to human IgG3. Even though they are all IgG, purification efficiency can vary greatly between subtypes — which is exactly why IgG subtype-specific resins matter.

2. Rabbit IgG Purification Resins: How to Choose for Polyclonal Antibodies?

Rabbit IgG purification resins are one of the most commonly needed tools in research. Rabbit polyclonal antibodies have high affinity and specificity and are widely used in WB, IP, IHC, ELISA, and other experiments. So which resin should be used for rabbit IgG? Many people answer, "Just grab Protein A" — that answer is half right.

**2.1 Binding characteristics of rabbit IgG**

Rabbit IgG binds well to both Protein A and Protein G, but Protein A shows stronger binding and milder elution conditions, making it the first choice for polyclonal rabbit IgG purification. Protein A strongly binds all major rabbit IgG subtypes, has high dynamic binding capacity, and elutes at a relatively gentle pH of about 3.0–3.5. Protein G can also bind rabbit IgG, but overall affinity is slightly lower. For specific rabbit IgG subtypes or Fc-engineered antibodies, Protein G can be used as a supplementary option.

**2.2 Context-based selection and practical tips**

For purifying rabbit polyclonal serum, Protein A resins are recommended; a single-step affinity purification can reach over 90% purity with high recovery and easy operation. Rabbit monoclonal antibodies also usually prefer Protein A, but Fc-engineered monoclonals need case-by-case evaluation. For immunoprecipitation experiments, use recombinant Protein A or Protein G magnetic beads with low non-specific binding for a cleaner background. Acid-sensitive rabbit antibodies can be purified using gentle-elution Protein A resins or a column-based online neutralization strategy.

There are three points to note in practice: first, serum samples should be centrifuged at 12,000 g and filtered through a 0.45 μm membrane before loading to avoid clogging the resin; second, elution should be done stepwise using 0.1 M glycine-HCl (pH 2.7–3.0) and immediately neutralized with 1 M Tris-HCl (pH 8.5); third, store the resin in PBS containing 20% ethanol at 2–8℃ and avoid freezing.

3. Human IgG Purification Resins: The Mainstream Choice from Research to Industry

Human IgG purification resins are essential consumables in fields such as antibody drug development, diagnostic reagent preparation, and IVIG (intravenous human immunoglobulin) production. The four human IgG subclasses have different binding characteristics, making resin selection more critical.

3.1 Binding Characteristics of Human IgG Subclasses

The differences in binding affinity of the four human IgG subclasses to Protein A and Protein G are the key basis for selecting IgG subclass purification resins. IgG1 and IgG2 bind strongly to both ligands and are easy to purify. IgG3 binds very weakly or not at all to Protein A, making it a known purification challenge, requiring the use of Protein G. IgG4 binds strongly to both ligands but is prone to Fab arm exchange, forming half-antibody molecules, so care must be taken to maintain molecular integrity during purification.

Functionally, IgG1 accounts for the highest proportion (about 60%) and is the most commonly used subtype for therapeutic antibodies; IgG3 accounts for the lowest proportion and has the shortest half-life (about 7 days), but it has the strongest complement activation ability.

3.2 Resin Selection in Three Major Scenarios & Special Attention to IgG3

For therapeutic antibodies or recombinant human IgG purification, IgG1, IgG2, and IgG4 are best purified using Protein A resins—high-quality industrial-grade products achieve dynamic binding capacities of over 50–60 mg/mL, are alkali-resistant, and allow mild elution, making them the gold standard for large-scale production; IgG3, however, must use Protein G or Protein A/G.

For total serum IgG purification, both Protein A and Protein G are suitable; if capturing all subclasses (including IgG3) is required, Protein G or Protein A/G is recommended to ensure no loss of IgG3. For diagnostic antibody preparation, high-capacity, low-leaching, alkali-resistant resins are recommended, and site-directed conjugated resins have even lower ligand leaching.

Human IgG3 is the most unusual subclass. Its inability to bind Protein A is mainly due to arginine at position 435 in the Fc CH3 domain (whereas IgG1/2/4 have histidine), which disrupts the key binding site of Protein A at the CH2–CH3 interface. Protein G resins are preferred for purifying IgG3, and elution pH is usually lower (around pH 2.5–2.7) and must be immediately neutralized to preserve activity.

4. IgG Subclass Purification Resins: From "All-in-One" to Precise Purification

 Visualisation of the purification workflows for two IgG subtypes

As antibody research advances, the demand for IgG subtype purification media is growing rapidly. Traditional 'total IgG purification' is no longer sufficient for scenarios such as autoimmune disease research, antibody drug subtype analysis, and vaccine immune response evaluation.

There are two main approaches to subtype purification. The first is to use ligand-based subtype selectivity. For example, using Protein A to remove IgG1/2/4 from human serum, leaving IgG3 enriched in the flow-through; or using Protein G to bind all four subtypes and then performing stepwise elution at different pH levels for partial separation. This method is simple and cost-effective but has limited separation capacity, usually achieving only enrichment rather than 100% purity.

The second approach is subtype-specific antibody affinity columns (immunoaffinity chromatography), which involves coupling monoclonal antibodies against each subtype to a matrix, using the high specificity of antigen-antibody interactions to achieve subtype separation. This method offers high specificity and excellent separation results but comes at a higher preparation cost, making it suitable for applications that require extremely high purity.

Selection recommendation: Matwings Mall AI-designed affinity media

Besides traditional Protein A/G media, a new generation of AI-designed ligands are opening up new possibilities for subtype purification. With the push for domestic production of biological reagents, high-performance domestic affinity media are providing users with more cost-effective options.

MatwingsVenus™ (Xiaowu™) platform under Shanghai Matwings Technology is the country's first full-stack protein R&D platform centered on intelligent entities, integrating computational design with automated wet lab experiments. Relying on nearly ten billion protein sequence datasets and a self-developed universal protein design model, it integrates over 200 design tools and more than 30 expert-tuning skills.

Based on this AI capability, Matwings Technology has launched its own line of affinity media on Matwings Mall, covering Protein A, Protein G, Protein L, VHH, and other ligands, fully covering core needs such as rabbit IgG purification media, human IgG purification media, and IgG subtype purification media.

The AI-designed affinity media achieves performance upgrades in two major directions:

First is the improvement of both performance and specificity. AI intelligently optimizes the Fc-binding interface, precisely modifying the arrangement of key amino acids, significantly enhancing the multi-antibody capture efficiency of rabbit IgG purification media; human IgG Protein G media can fully recover IgG3 with noticeably improved yield; IgG subtype-specific ligands can also be customized for efficient single-subtype separation. Additionally, surface charge engineering optimizes protein hydrophilicity, significantly reducing residual contaminating proteins in serum or cell supernatant purification, meeting the high purity requirements of diagnostic reagents.

Second, stability and batch consistency upgrades. AI targeted replacement of deamidation-sensitive sites such as Asn/Gln allows alkali-resistant ligands to stably withstand in-place cleaning with 0.1–0.5 M NaOH. When used according to industrial-grade CIP protocols, the product life can exceed a hundred uses (with ≥80% binding capacity retention considered acceptable), significantly reducing the cost of consumable replacements on production lines. Directional site-specific coupling technology for end-users exposes the ligands uniformly outward to the binding region, with ligand shedding rates below pharmacopeia standards for biologics, and key performance indicators maintain extremely low batch-to-batch RSD, meeting the strict requirements of GMP commercial production.

Beyond standard products, Matwings Mall also offers customized IgG subtype purification resin development services. For special subtypes, bispecifics/ADCs/Fc fusion proteins, and other customized needs, AI designs and customizes ligands from scratch based on target structures, providing full-chain support from design to process verification.

6. Frequently Asked Questions

Q: Do rabbit IgGs always need Protein A?

A: Most of the time, yes, because it binds strongly, elutes gently, and has a high recovery rate. If you encounter special subtypes or Fc-modified antibodies with abnormal binding, you can try Protein G.

Q: Why are human IgG3s always lost?

A: Most likely because Protein A resins were used. Protein A binds very weakly to human IgG3, which flows through and is lost. To retain all subtypes, switch to Protein G or Protein A/G resins.

Q: What are the common pitfalls in subtype purification?

A: Three common mistakes: First, using only Protein A can completely lose IgG3 or mouse IgG1, leading to severely skewed quantification. Second, improper pH gradient settings during stepwise elution can cause cross-contamination between subtypes; pre-experiments are needed to optimize conditions. Third, skipping subtype identification before purification and choosing resins based on experience can lead to poor recovery.

Q: Can one column completely separate all subtypes?

A: It’s hard to achieve 100% separation with only Protein A or Protein G; usually, you can achieve enrichment. For high-purity specific subtypes, it’s recommended to use subtype-specific antibody affinity columns or combine multiple steps like ion exchange and hydrophobic chromatography.

Q: How many times can the resin be used?

A: Research-grade ordinary resins can be reused 5–10 times under mild conditions; industrial-grade alkali-resistant resins with standard CIP operations can usually be used more than 100 times (≥80% binding capacity retention is the standard).

Conclusion:

From rabbit polyclonals to human monoclonals, from total IgG to subtype-specific purification, IgG purification is much more complex than 'one Protein A column for everything.' Understanding the binding characteristics of different species and subtypes and choosing the appropriate IgG subtype purification resins is the first step to obtaining high-purity, highly active antibodies. AI-designed next-generation affinity resins are providing a higher-performance, lower-cost domestic option for rabbit and human IgG purification.